App Store Screenshots Description MeAgain is the GLP-1 tracker app for shots and pills the simple place to track every dose and everything in between
And sitting at the centre of this transition is Eli Lillys emerging oral drug, orforglipron, which many are already informally calling Ozempic 2.0
The European Medicines Agencys 2025 synthetic peptide quality guideline treats peptide-related impurities as first-class critical quality attributes: deletion and truncated sequences, dimers, oligomers, and degradation products each need characterization, with European Pharmacopoeia practice pointing to reporting thresholds at 0.1% and identification thresholds above 0.5% for peptide-related impurities in pharmaceutical use
This is where some researchers deviate from the one-vial approach
Dosage adjustments are only required in patients with severe renal insufficiency
Moreover, regenerative therapies align with the central pathology of EDS (collagen dysfunction) in a way that standard pain medications or surgeries do not: they aim to improve the quality of the collagenous tissue